Skip to main content

Advertisement

Table 1 Baseline clinical characteristics of the participants or patients study participants

From: Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes

Variables
No. patients 57
Sex, male/female 39/18
Age (years) 67.2 ± 7.7
BMI (kg/m2) 25.4 ± 4.2
Duration of diabetes (years) 11.5 ± 9.6
Fasting plasma glucose (mg/dL) 134.7 ± 30.7
HbA1c (%) 7.3 ± 1.0
Long-term data
 No. HbA1c measurements in 2 years (times/2 years) 14.8 ± 4.7
 Two-year mean HbA1c (%) 7.2 ± 1.0
 HbA1c CV (%) 0.049 (0.029–0.080)
 HbA1c SD (%) 0.33 (0.18–0.62)
 Adjusted HbA1c SD (%) 0.32 (0.18–0.59)
Short-term data
 CGM mean glucose (mg/dL) 154.5 ± 28.8
 CGM CV (mg/dL) 23.6 ± 7.1
 CGM SD (mg/dL) 36.7 ± 13.2
Hypertension, n (%) 42 (74)
Blood pressure (mmHg)
 Systolic 124.6 ± 17.0
 Diastolic 77.1 ± 9.4
Heart rate (beats/min) 69.3 ± 11.8
Dyslipidemia, n (%) 51 (89)
Lipid profile (mg/dL)
 Triglycerides 115 (100–175)
 LDL-cholesterol 111.0 ± 30.2
 HDL-cholesterol 52.8 ± 15.5
BRS (msec/mmHg) 7.6 ± 2.7
  1. Values are mean ± SD, or median (25th–75th percentiles) or no. (%)
  2. BMI body mass index, SD standard deviation, CV coefficient of variation, CGM continuous glucose monitoring, LDL low-density lipoprotein, HDL high-density lipoprotein, BRS baroreflex sensitivity